Third Cranial Nerve Palsy after Monoclonal Antibody Therapy for Lung Cancer: A Case Report

Immune checkpoint inhibitors (ICIs) have shown promise in treating cancer patients, and pembrolizumab is a monoclonal IgG4 antibody that targets a human cell surface protein (receptor) called PD-1. Among the side effects, a rare cranial nerve palsy unrelated to the surgical treatment may occur. We r...

Descripción completa

Detalles Bibliográficos
Autores principales: Missori, Paolo, Ambrosone, Angela, Cristofani, Leonardo, Fattapposta, Francesco, Currà, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149351/
https://www.ncbi.nlm.nih.gov/pubmed/35702522
http://dx.doi.org/10.1159/000524114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149351/
https://www.ncbi.nlm.nih.gov/pubmed/35702522
http://dx.doi.org/10.1159/000524114

Ejemplares similares